Skip to content

Florida Scientists Revolutionize Cancer Treatment with mRNA Vaccines

A groundbreaking combination of mRNA vaccines and immunotherapy drugs shrinks tumours in mice. Human trials could be next.

This is a poster in this image there is some text, and there is chicken.
This is a poster in this image there is some text, and there is chicken.

Florida Scientists Revolutionize Cancer Treatment with mRNA Vaccines

Scientists at the University of Florida have made a significant breakthrough in cancer treatment. They've combined mRNA vaccines with immune-stimulating agents to successfully combat various types of tumours in mice. The promising results could pave the way for human trials.

The research team discovered a way to 'wake up' the immune system using mRNA vaccines and a commonly used immunotherapy drug. This combination reduced tumour size and growth within days in mice with skin, lung, and brain cancers. Notably, the cancer-targeting effect wasn't limited to the initial tumour. It also spread to other cancer cells with different 'red flag' proteins, demonstrating the strategy's potential to tackle multiple types of cancer.

The mRNA vaccines work by generating proteins that signal the presence of cancer cells, revving up the immune system. They were engineered to stimulate the interferon response, guiding immune cells past a cancer's molecular barrier. This barrier, created by cancer cells, usually reduces immune-cell efficacy and prevents recognition of dangerous cells. The team found that increasing interferon activity initially led to worse health outcomes in mice with multiple types of tumours. However, with the right approach, it can be harnessed to enhance immunotherapy treatment.

The University of Florida team is now working towards a clinical trial to test the safety and efficacy of these mRNA vaccines in humans. If successful, this treatment could bolster immunotherapy for multiple cancers, as it's not specific to any one type of cancer. The potential to educate the immune system to go after multiple dangerous proteins is a significant step forward in cancer treatment.

Read also:

Latest